Michael A. Mussallem, Chairman & CEO at Edwards Lifesciences Corp (EW), sold 48,950 shares at $76.93 ($3.0M) on 2022-12-14, disclosed to the SEC on 2022-12-14.
Seasonal sale ($3.0M) by Chairman & CEO — this insider has traded EW in December in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 9,500 | $0 | 0.0% |
| 2 | $76.04 | 12,155 | $924K | 30.7% |
| 3 | $76.04 | 12,155 | $924K | 30.7% |
| 4 | $76.93 | 7,420 | $571K | 18.9% |
| 5 | $76.93 | 7,420 | $571K | 18.9% |
| 6 | $77.51 | 300 |
| $23K |
| 0.8% |
| Total | $61.56 avg | 48,950 | $3.0M | 100% |
| Filing → |
| EW | SELL | 2024-03-04 | $3.7M | — | Filing → |
| EW | SELL | 2024-02-05 | $5.0M | — | Filing → |
| EW | SELL | 2024-01-05 | $2.3M | — | Filing → |